Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Not applicableStudy completedNCT06024681
What this trial is testing

Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation
Imperial College London 16
Not applicableUnknownNCT05443581
What this trial is testing

The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease

Who this might be right for
Metabolism and Nutrition DisorderLiver DiseasesObesity+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 220
Not applicableUnknownNCT04298736
What this trial is testing

Bariatric Surgery vs. Lifestyle Modification for NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hospital de Clinicas de Porto Alegre 50
Not applicableUnknownNCT02083159
What this trial is testing

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Korea University 500
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Not applicableStudy completedNCT00868933
What this trial is testing

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Chinese University of Hong Kong 159
Not applicableStudy completedNCT02820285
What this trial is testing

Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

Who this might be right for
Non Alcoholic Fatty Liver Disease
Centre Hospitalier Universitaire de Nice 148
Not applicableStudy completedNCT07265011
What this trial is testing

Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD

Who this might be right for
MASLDPediatric
Jae Won Choi 50
Not applicableNot Yet RecruitingNCT06563921
What this trial is testing

RE and Probiotics in MAFLD/NAFLD

Who this might be right for
NASHNAFLDMAFLD
Nicolaus Copernicus University 180
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Testing effectiveness (Phase 2)Ended earlyNCT02605616
What this trial is testing

Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
University of Alabama at Birmingham 93
Post-approval studies (Phase 4)Not Yet RecruitingNCT07180745
What this trial is testing

Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease NAFLDNon-alcoholic Steatohepatitis NASH
Badr University 400
Large-scale testing (Phase 3)Study completedNCT03439254
What this trial is testing

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
Intercept Pharmaceuticals 919
Not applicableStudy completedNCT03861819
What this trial is testing

Feasibility of VIIT in Adults With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis+1 more
Duke University 24
Not applicableUnknownNCT03972631
What this trial is testing

Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
First Affiliated Hospital of Zhejiang University 292
Early research (Phase 1)Study completedNCT03681457
What this trial is testing

Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 42
Not applicableUnknownNCT01511523
What this trial is testing

Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
Biovil Research Group, LLC 40
Not applicableEnrolling By InvitationNCT05956379
What this trial is testing

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Who this might be right for
Chronic Hepatitis BNon-alcoholic Fatty Liver Disease
National Taiwan University Hospital 100
Not applicableLooking for participantsNCT02206841
What this trial is testing

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Who this might be right for
Fibrosis of Liver
Seoul National University Boramae Hospital 1,000
Next Page